Related references
Note: Only part of the references are listed.Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
A. P. Barbour et al.
ANNALS OF ONCOLOGY (2020)
Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis
Hector G. van den Boorn et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)
Hai-Yu Zhou et al.
ECLINICALMEDICINE (2020)
Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis
Shao-wu Jing et al.
FUTURE ONCOLOGY (2019)
Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial)
B. Sunde et al.
BRITISH JOURNAL OF SURGERY (2019)
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
Justyna Mierzynska et al.
LANCET ONCOLOGY (2019)
Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis
Kelvin K. W. Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial
Bo Jan Noordman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials
Xin Zhao et al.
PLOS ONE (2018)
Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma A Network Meta-analysis
Sandro Pasquali et al.
ANNALS OF SURGERY (2017)
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET ONCOLOGY (2016)
Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review
Rebecca Mercieca-Bebber et al.
BMJ OPEN (2016)
Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension
Melanie Calvert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Functional Performance and Quality of Life in Patients With Squamous Esophageal Carcinoma Receiving Surgery or Chemoradiation Results From a Randomized Trial
Anthony Yuen Bun Teoh et al.
ANNALS OF SURGERY (2011)
Thoracoscopic-Assisted Esophagectomy for Esophageal Cancer Analysis of Patterns and Prognostic Factors for Recurrence
Iain G. Thomson et al.
ANNALS OF SURGERY (2010)
Preoperative and Early Postoperative Quality of Life Predict Survival in Potentially Curable Patients with Esophageal Cancer
Mark van Heijl et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
Michael Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Refining esophageal cancer staging after neoadjuvant therapy: Importance of treatment response
Andrew P. Barbour et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Factors predicting survival in patients with advanced oesophageal cancer:: a prospective multicentre evaluation
H. Bergquist et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia
JM Blazeby et al.
BRITISH JOURNAL OF SURGERY (2005)
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
JM Blazeby et al.
EUROPEAN JOURNAL OF CANCER (2003)
Share Paper
